ArticleJournal of assisted reproduction and genetics2025
Association of age, AMH, and gonadotropin dosing on IVF outcomes in fertility preservation cycles for patients less than 35 undergoing chemotherapeutic treatment: A retrospective cohort study.
Article in Journal of assisted reproduction and genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the differences in total number of oocytes and MII oocytes retrieved with gonadotropin dosing in adolescent and young adult patients compared to older patients undergoing fertility preservation cycles for cancer diagnosis.
designRetrospective cohort.
settingSingle academic institution. PATIENT(S): All patients less than 35 years old undergoing a fertility preservation cycle who have a cancer diagnosis, or a plan to receive gonadotoxic chemotherapy. INTERVENTION(S): Fertility preservation cycles in patients < 22 years old (younger group) compared with those 22- < 35 years old (older group) stratifying by age, AMH, and average daily gonadotropin dosing. MAIN OUTCOME MEASURE(S): Total oocyte yield, total number of MII oocytes.
resultsThe younger group had 26% more oocytes retrieved and 28% more MII oocytes retrieved compared with the older group, when adjusting for BMI, chemotherapy prior to treatment and myelodysplasia (aRR 1.28, 95% CI 1.01-1.63). Starting, total, and average daily gonadotropin doses were similar between age groups. Cycles in the younger group (10.0%) were more likely to be canceled compared with the older group (2.8%) (RR 3.52, 95% CI 1.35-0.17); 35.9% of the younger group and 11.7% of the older group had chemotherapy prior to cycle start. CONCLUSION(S): Patients should be encouraged to undergo fertility preservation prior to receiving chemotherapy as this commonly decreases ovarian reserve and leads to a higher likelihood of cycle cancellation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.